HERG Screening Market Size, Share, Growth Analysis, By Application(Discovery, Safety Pharmacology, and Preclinical Research), By Technology(Automated Patch Clamp Systems, High-Throughput Screening, and Manual Patch Clamp Systems), By End-User(Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), Academic and Research Institutions), By Region - Industry Forecast 2024-2031

Global HERG Screening Market size was valued at USD 1.9 billion in 2022 and is poised to grow from USD 2.18 billion in 2023 to USD 6.63 billion by 2031, growing at a CAGR of 14.8% in the forecast period (2024-2032).

The global hERG screening marketplace has witnessed regular increase in current years due to the increasing emphasis on drug protection and the rising demand for extra green screening strategies. The pharmaceutical and biotechnology industries are the number one drivers of this marketplace, as they always searching for dependable screening technologies to minimize the danger of drug-precipitated cardiac arrhythmias.

 Growing focus of the capacity cardiotoxicity of medicine has heightened the significance of hERG screening in the drug development technique. Continuous improvements in screening technologies, such as automatic patch clamp structures and high-throughput screening techniques, contribute to the market's growth. Stringent regulatory requirements concerning drug protection have led pharmaceutical groups to invest in hERG screening technologies to conform with recommendations.

The preliminary funding required for advanced screening gadget can be a restricting element for smaller pharmaceutical companies and research institutions. Complexity of Cardiac Safety Assessment: Despite advancements, appropriately predicting the cardiac protection profile of a drug stays tough, and there may be ongoing research to improve predictive fashions.